J&J Vision, Sight Sciences add to executive teams
Business

J&J Vision, Sight Sciences add to executive teams

Companies announce the appointment of industry veterans Erin Powers and Matt Link, respectively.
Optometric task force releases new report on DR management
Research

Optometric task force releases new report on DR management

Consensus document is designed to simplify and standardize disease assessment and management to avoid preventable vision loss associated with DR.
FDA clears NeoLight's Icon Go portable ophthalmic retinal imaging system
Products

FDA clears NeoLight's Icon Go portable ophthalmic retinal imaging system

Device provides high-resolution and high-contrast imaging for screening newborn patients.
National study assesses risk of uveitis after COVID vaccination
Research

National study assesses risk of uveitis after COVID vaccination

Researchers note significance of gender and vaccination type in determining an increased incidence risk.
VSP Vision launches Student Loan Repayment Program
Business

VSP Vision launches Student Loan Repayment Program

Program will provide up to $50,000 for a select number of participants and locations.
NovaBay launches Avenova Allograft in the US
Products

NovaBay launches Avenova Allograft in the US

Prescription-based product was recently acquired and rebranded from BioStem Technologies.
 Positive 24-month data reported in phase 3 study of IZERVAY for GA
Products

Positive 24-month data reported in phase 3 study of IZERVAY for GA

Updated safety and efficacy results follow 12-month data from the GATHER1 and GATHER2 trials.
FDA grants Altris IMS platform 510(k) clearance
Products

FDA grants Altris IMS platform 510(k) clearance

Artificial intelligence-based system is designed to store, organize, and support an in-depth analysis of OCT scans.
First annual Eyes on Retina exceeds attendance expectations
Events

First annual Eyes on Retina exceeds attendance expectations

One-day virtual event featured the latest in retinal research, education, and specialized treatments.
OCT-A reveals retinal findings after Parkinson's disease diagnosis
Research

OCT-A reveals retinal findings after Parkinson's disease diagnosis

Study identifies rapid decrease in retinal microvascular perfusion and other key indicators.
Is thermal pulsation effective for MGD in dry eye?
Research

Is thermal pulsation effective for MGD in dry eye?

Investigators assessed the use of the LipiFlow system against conventional therapies.
Registration opens for Eyes On 2024
Events

Registration opens for Eyes On 2024

Annual two-day meeting offers 6 hours of free CE, promising a lineup of expert-led accredited sessions.
Decreased corneal sensitivity may be indicative of PDR
Research

Decreased corneal sensitivity may be indicative of PDR

New study suggests adding corneal sensitivity testing to list of screening tools for DR.
Anti-VEGF therapy may maintain VA for nAMD in the long-term
Research

Anti-VEGF therapy may maintain VA for nAMD in the long-term

Retrospective study looks at 10 years of nAMD patients’ PRN regimen outcomes on visual acuity.
Noninvasive imaging technique may improve ocular disease diagnosis and treatment
Research

Noninvasive imaging technique may improve ocular disease diagnosis and treatment

Shear wave speeds could be used to track tissue stiffness in the eye.
Is low-intensity red light effective for myopia?
Research

Is low-intensity red light effective for myopia?

Findings indicate a significant reduction in axial length elongation and increased choroidal thickness.
Théa Open Innovation, Link Biologics partner on DED drug
Pipeline

Théa Open Innovation, Link Biologics partner on DED drug

Biologic-based Link_TSG6 has been found to accelerate corneal wound healing, increase tear production, and reduce inflammation.
FDA issues warning letters to 8 companies over unapproved eye products
Products

FDA issues warning letters to 8 companies over unapproved eye products

Agency calls out Walgreens, CVS, and others for illegally manufacturing or marketing ophthalmic drugs for certain conditions.
HCP Cureblindness marks 200,000 corneal transplants
Business

HCP Cureblindness marks 200,000 corneal transplants

With SightLife International, the nonprofits are working to eliminate preventable blindness across the globe. 
Bausch + Lomb launches MIEBO in the US
Products

Bausch + Lomb launches MIEBO in the US

Preservative-free eye drop is the first and only approved DED treatment that directly targets tear evaporation.